From human tissue to animal models: Insights into the pathogenesis of cortical dysplasia

Epilepsia

Volumn 50, Issue SUPPL. 9, 2009, Pages 28-33

  D'Arcangelo, Gabriella ^a  

^a State University of New Jersey   (United States)

Author keywords

Cerebral cortex; Epilepsy; MTOR; Tuberous sclerosis

Indexed keywords

AMPA RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN; TEMSIROLIMUS;

BENIGN CHILDHOOD EPILEPSY; BRAIN CORTEX; CORTICAL DYSPLASIA; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTOGENESIS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; MOLECULAR GENETICS; NEUROANATOMY; NEUROFILAMENT; NEUROTRANSMISSION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

ANIMALS; BIOPSY; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EPILEPSY; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 70349193008     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02290.x     Document Type: Review

References (44)

1. Abraham RT 2002) Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell 111 : 9 12.
2. Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, Vinters HV, Levine MS, Mathern GW 2004) NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 14 : 634 646.
3. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Ramkema M, Troost D 2003) Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia. Epilepsia 44 : 785 795.
4. Avoli M, Louvel J, Mattia D, Olivier A, Esposito V, Pumain R, D'Antuono M 2003) Epileptiform synchronization in the human dysplastic cortex. Epileptic Disord 5 (suppl 2 S45 S50.
5. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, Mak TW 2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29 : 396 403.
6. Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G II., Aronica E, Crino PB 2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56 : 478 487.
7. Boer K, Troost D, Timmermans W, Gorter JA, Spliet WG, Nellist M, Jansen F, Aronica E 2008) Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Neuroscience 156 : 203 215.
8. Cepeda C, Hurst RS, Flores-Hernandez J, Hernandez-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, Andre VM, Vinters HV, Ariano MA, Levine MS, Mathern GW 2003) Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 72 : 472 486.
9. Cepeda C, Andre VM, Levine MS, Salamon N, Miyata H, Vinters HV, Mathern GW 2006) Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 9 : 219 235.
10. Crino PB 2007) Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis Found Symp 288 : 260 272.
11. Curatolo P, Bombardieri R, Jozwiak S 2008) Tuberous sclerosis. Lancet 372 : 657 668.
12. Datta AN, Hahn CD, Sahin M 2008) Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol 23 : 268 273.
13. Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF 2005). Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol (Berl) 109 : 519 533
14. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR 2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59 : 490 498.
15. Harris TE, Lawrence JC Jr. 2003) TOR signaling. Sci STKE 2003 : re15.
16. Holmes GL, Stafstrom CE 2007) Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 48 : 617 630.
17. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ 2001) Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29 : 404 411.
18. Kwon CH, Zhu X, Zhang J, Baker SJ 2003) mTOR is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U.S.A. 100 : 12923 12928.
19. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF 2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50 : 377 388.
20. Leevers SJ, Vanhaesebroeck B, Waterfield MD 1999) Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 11 : 219 225.
21. Lerner JT, Salamon N, Hauptman JS, Velasco TR, Hemb M, Wu JY, Sankar R, Donald Shields W, Engel J Jr., Fried I, Cepeda C, Andre VM, Levine MS, Miyata H, Yong WH, Vinters HV, Mathern GW 2009) Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 50, 1310 1335.
22. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R 1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 : 1943 1947.
23. Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, Sheldon M, D'Arcangelo G 2006) Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60 : 420 429.
24. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G 2009). Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2 : 389 398.
25. Luders H, Schuele SU 2006) Epilepsy surgery in patients with malformations of cortical development. Curr Opin Neurol 19 : 169 174.
26. Maehama T, Dixon JE 1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273 : 13375 13378.
27. Madan N, Grant PE 2009) New directions in clinical imaging of cortical dysplasias. Epilepsia 50 (Suppl. 9 9 18.
28. Mischel PS, Nguyen LP, Vinters HV 1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54 : 137 153.
29. Miyata H, Chiang AC, Vinters HV 2004) Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56 : 510 519.
30. Orloff MS, Eng C 2008) Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 27 : 5387 5397.
31. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV 2004) Terminology and classification of the cortical dysplasias. Neurology 62 : S2 S8.
32. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R 1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96 : 1563 1568.
33. Sarbassov DD, Ali SM, Sabatini DM 2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17 : 596 603.
34. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW 1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8 : 1169 1178.
35. Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE 2008) Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 63 : 454 465.
36. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA 1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34 : 369 387.
37. The European Chromosome 16 Tuberous Sclerosis Consortium (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305 1315.
38. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM 2005) Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 110 : 383 392. (Pubitemid 41672183)
39. Tsang CK, Qi H, Liu LF, Zheng XF 2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12 : 112 124.
40. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ 1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805 808. (Pubitemid 27366729)
41. Varga EA, Pastore M, Prior T, Herman GE, McBride KL 2009) The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11 : 111 117.
42. Wang VY, Chang EF, Barbaro NM 2006) Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome. Neurosurg Focus 20 : E7.
43. Wong M 2009) Animal models of focal cortical dysplasia and tuberous sclerosis complex: Recent progress toward clinical applications. Epilepsia 50 (Suppl. 9 34 44.
44. Zeng L-H, Xu L, Gutman DH, Wong M 2008) Rapamycin prevents epilepsy in a mouse model of Tuberous Sclerosis Complex. Ann Neurol 63 : 444 453.